Clinical Trial Update: Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intra-peritoneal catumaxomab infusion to investigator's treatment of choice in advanced gastric cancer with peritoneal metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stomach Neoplasms

Drugs mentioned

• Catumaxomab (Catumaxomab)

Snippet

Sponsor: LintonPharm Co.,Ltd. | Conditions: Stomach Neoplasms | Phase 3 | Status: UNKNOWN